177 related articles for article (PubMed ID: 11441276)
1. Targeted inhibition of telomerase in human cancer: will it be a double-edged sword?
Sasgary S; Wieser M; Cerni C
Onkologie; 2001 Feb; 24(1):22-6. PubMed ID: 11441276
[TBL] [Abstract][Full Text] [Related]
2. Telomeres, telomerase, and myc. An update.
Cerni C
Mutat Res; 2000 Jan; 462(1):31-47. PubMed ID: 10648922
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
Tárkányi I; Aradi J
Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
[TBL] [Abstract][Full Text] [Related]
4. [Telomerase: an enzyme with multiple applications in cancer research].
Castillo Ureta H; Barrera Saldaña HA; Martínez Rodríguez HG
Rev Invest Clin; 2002; 54(4):342-8. PubMed ID: 12415959
[TBL] [Abstract][Full Text] [Related]
5. Telomeres, telomerase and cancer: is the magic bullet real?
Sharma HW; Maltese JY; Zhu X; Kaiser HE; Narayanan R
Anticancer Res; 1996; 16(1):511-5. PubMed ID: 8615664
[TBL] [Abstract][Full Text] [Related]
6. [Telomeres and telomerase as targeted therapies in cancer treatment].
Souiden Y; Bouraoui A; Chaieb K; Mahdouani K
Bull Cancer; 2010 Sep; 97(9):1087-104. PubMed ID: 20663741
[TBL] [Abstract][Full Text] [Related]
7. Telomerase inhibitors in cancer therapy: current status and future directions.
Incles CM; Schultes CM; Neidle S
Curr Opin Investig Drugs; 2003 Jun; 4(6):675-85. PubMed ID: 12901225
[TBL] [Abstract][Full Text] [Related]
8. Telomerase inhibitors as anticancer therapy.
Akiyama M; Hideshima T; Munshi NC; Anderson KC
Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):567-75. PubMed ID: 12678724
[TBL] [Abstract][Full Text] [Related]
9. [Physiopathologic implications of telomerase].
Santos Ruiz A; Cascales Angosto M
An R Acad Nac Med (Madr); 2000; 117(2):427-44; discussion 444-7. PubMed ID: 11209552
[TBL] [Abstract][Full Text] [Related]
10. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
Kelland LR
Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
[TBL] [Abstract][Full Text] [Related]
11. [Telomeres, telomerase and cancer].
Soria JC; Rixe O
Bull Cancer; 1997 Oct; 84(10):963-70. PubMed ID: 9435798
[TBL] [Abstract][Full Text] [Related]
12. Telomerase as a diagnostic and therapeutic target for cancer.
Doyle LA; Highsmith WE
Expert Rev Anticancer Ther; 2002 Apr; 2(2):217-25. PubMed ID: 12113243
[TBL] [Abstract][Full Text] [Related]
13. Aging and cancer: are telomeres and telomerase the connection?
Shay JW
Mol Med Today; 1995 Nov; 1(8):378-84. PubMed ID: 9415184
[TBL] [Abstract][Full Text] [Related]
14. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.
Rankin AM; Faller DV; Spanjaard RA
Anticancer Drugs; 2008 Apr; 19(4):329-38. PubMed ID: 18454043
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of telomerase limits the growth of human cancer cells.
Hahn WC; Stewart SA; Brooks MW; York SG; Eaton E; Kurachi A; Beijersbergen RL; Knoll JH; Meyerson M; Weinberg RA
Nat Med; 1999 Oct; 5(10):1164-70. PubMed ID: 10502820
[TBL] [Abstract][Full Text] [Related]
16. [Telomere and telomerase in human cancer].
Hiyama K; Hiyama E; Ishioka S; Yamakido M
Gan To Kagaku Ryoho; 1997 Jan; 24(2):196-201. PubMed ID: 9030230
[TBL] [Abstract][Full Text] [Related]
17. Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells.
Saretzki G; Ludwig A; von Zglinicki T; Runnebaum IB
Cancer Gene Ther; 2001 Oct; 8(10):827-34. PubMed ID: 11687906
[TBL] [Abstract][Full Text] [Related]
18. Effects of oligonucleotide N3'-->P5' thio-phosphoramidate (GRN163) targeting telomerase RNA in human multiple myeloma cells.
Akiyama M; Hideshima T; Shammas MA; Hayashi T; Hamasaki M; Tai YT; Richardson P; Gryaznov S; Munshi NC; Anderson KC
Cancer Res; 2003 Oct; 63(19):6187-94. PubMed ID: 14559802
[TBL] [Abstract][Full Text] [Related]
19. Resistance to telomerase inhibition by human squamous cell carcinoma cell lines.
Bojovic B; Crowe DL
Int J Oncol; 2011 Apr; 38(4):1175-81. PubMed ID: 21305252
[TBL] [Abstract][Full Text] [Related]
20. Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics.
Seimiya H; Muramatsu Y; Ohishi T; Tsuruo T
Cancer Cell; 2005 Jan; 7(1):25-37. PubMed ID: 15652747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
